Malaria is a critical global health challenge caused by Plasmodium parasites, with Plasmodium falciparum being the most deadly. Current rapid diagnostic tests (RDTs) rely on reagents vulnerable to heat and humidity, leading to reduced shelf life and diagnostic accuracy in tropical regions. SalamAB-malaria, a trademarked antigen binder, offers a groundbreaking solution by incorporating shark VNAR antibodies with remarkable thermal stability. This innovative diagnostic reagent targets the P. falciparum HRP2 biomarker, ensuring accuracy even in extreme environments. By enabling room-temperature storage, SalamAB-malaria improves access to reliable diagnostics, particularly in remote areas, supporting effective disease control and appropriate drug use.
.jpg)
